Unicocell Biomed Co., Ltd. (6794)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
74. 70
0
0%
NT$
- Market Cap
- P/E Ratio
90% Div Yield
30,000 Volume
- Eps
NT$ 74.7
Previous Close Want to track 6794 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Unicocell Biomed Co., Ltd. (6794) Statistics
Valuation metrics
Market Cap -
Enterprise value 4.76B
Trailing P/E (ttm) -39.37
Forward P/E -
PEG ratio 1.84
Price/Sales (ttm) 157.28
Price/Book (mrq) 5.24
Enterprise Value/Revenue 157.98
Enterprise Value/EBITDA -43.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 41.25K
Average volume (90 days) 48.25K
Price summary
52-Week low 60.8
52-Week high 96
Beta -
50-Day moving average 78.4
200-Day moving average 81.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.81%
Operating margin -4.33%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.49
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 37.98%
Book value per share (mrq) 14.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
